{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:55:08Z","timestamp":1767988508236,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Dicle University Scientific Project Unit (DUBAP)","award":["14-TF-48"],"award-info":[{"award-number":["14-TF-48"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00408-016-9868-1","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T06:57:43Z","timestamp":1459407463000},"page":"409-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure"],"prefix":"10.1007","volume":"194","author":[{"given":"Melike","family":"Demir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halide","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsuk","family":"Taylan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysun","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sureyya","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Teke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cengizhan","family":"Sezgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah Cetin","family":"Tanrikulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Meteroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdurrahman","family":"Senyigit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"issue":"1","key":"9868_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00408-013-9526-9","volume":"192","author":"M Bayram","year":"2014","unstructured":"Bayram M, Dongel I, Akbas A, Benli I, Akkoyunlu ME, Bakan ND (2014) Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos. Lung 192(1):197\u2013203","journal-title":"Lung"},{"issue":"3","key":"9868_CR2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.lungcan.2015.09.021","volume":"90","author":"L Santarelli","year":"2015","unstructured":"Santarelli L, Staffolani S, Strafella E et al (2015) Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma. Lung Cancer 90(3):457\u2013464","journal-title":"Lung Cancer"},{"issue":"11","key":"9868_CR3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1440-1827.2006.02024.x","volume":"56","author":"M Maeda","year":"2006","unstructured":"Maeda M, Hino O (2006) Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers. Pathol Int 56(11):649\u2013654","journal-title":"Pathol Int"},{"issue":"Suppl 1","key":"9868_CR4","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.lungcan.2005.03.020","volume":"49","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I (2005) Soluble mesothelin-related protein\u2014a blood test for mesothelioma. Lung Cancer 49(Suppl 1):S109\u2013S111","journal-title":"Lung Cancer"},{"issue":"10","key":"9868_CR5","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1515\/CCLM.2011.242","volume":"49","author":"S Yamada","year":"2011","unstructured":"Yamada S, Tabata C, Tabata R, Fukuoka K, Nakano T (2011) Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma. Clin Chem Lab Med 49(10):1721\u20131726","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"9868_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/07357907.2012.749265","volume":"31","author":"PA Canessa","year":"2013","unstructured":"Canessa PA, Franceschini MC, Ferro P et al (2013) Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology. Cancer Invest 31(1):43\u201350","journal-title":"Cancer Invest"},{"issue":"2","key":"9868_CR7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/1055-9965.EPI-08-0422","volume":"18","author":"JA Rodriguez Portal","year":"2009","unstructured":"Rodriguez Portal JA, Rodriguez Becerra E, Rodriguez Rodriguez D et al (2009) Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure. Cancer Epidemiol Biomarkers Prev 18(2):646\u2013650","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 4","key":"9868_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1634\/theoncologist.7-suppl_4-31","volume":"7","author":"CL Arteaga","year":"2002","unstructured":"Arteaga CL (2002) Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7(Suppl 4):31\u201339","journal-title":"Oncologist"},{"issue":"2","key":"9868_CR9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/PDM.0b013e3182a3645e","volume":"23","author":"V Schildgen","year":"2015","unstructured":"Schildgen V, Pabst O, Tillmann RL et al (2015) Low frequency of EGFR mutations in pleural mesothelioma patients, Cologne, Germany. Appl Immunohistochem Mol Morphol 23(2):118\u2013125","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"9868_CR10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lungcan.2010.01.002","volume":"70","author":"R Gaafar","year":"2010","unstructured":"Gaafar R, Bahnassy A, Abdelsalam I et al (2010) Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma. Lung Cancer 70(1):43\u201350","journal-title":"Lung Cancer"},{"issue":"12","key":"9868_CR11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.embor.7400033","volume":"4","author":"WS Argraves","year":"2003","unstructured":"Argraves WS, Greene LM, Cooley MA, Gallagher WM (2003) Fibulins: physiological and disease perspectives. EMBO Rep 4(12):1127\u20131131","journal-title":"EMBO Rep"},{"issue":"3","key":"9868_CR12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.exer.2009.09.018","volume":"90","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Marmorstein LY (2010) Focus on molecules: fibulin-3 (EFEMP1). Exp Eye Res 90(3):374\u2013375","journal-title":"Exp Eye Res"},{"key":"9868_CR13","doi-asserted-by":"crossref","first-page":"419853","DOI":"10.1155\/2014\/419853","volume":"2014","author":"F Mundt","year":"2014","unstructured":"Mundt F, Heidari-Hamedani G, Nilsonne G, Metintas M, Hjerpe A, Dobra K (2014) Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies. Biomed Res Int 2014:419853","journal-title":"Biomed Res Int"},{"issue":"4","key":"9868_CR14","first-page":"1106","volume":"116","author":"AM Todosi","year":"2012","unstructured":"Todosi AM, Gavrilescu MM, Anitei GM, Filip B, Scripcariu V (2012) Colon cancer at the molecular level\u2013usefulness of epithelial-mesenchymal transition analysis. Rev Med Chir Soc Med Nat Iasi 116(4):1106\u20131111","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"6","key":"9868_CR15","doi-asserted-by":"crossref","first-page":"e14816","DOI":"10.1371\/journal.pone.0014816","volume":"6","author":"F Zong","year":"2011","unstructured":"Zong F, Fthenou E, Mundt F et al (2011) Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration. PLoS ONE 6(6):e14816","journal-title":"PLoS ONE"},{"key":"9868_CR16","doi-asserted-by":"crossref","first-page":"902748","DOI":"10.1155\/2014\/902748","volume":"2014","author":"C Sezgi","year":"2014","unstructured":"Sezgi C, Taylan M, Sen HS et al (2014) Oxidative status and acute phase reactants in patients with environmental asbestos exposure and mesothelioma. Sci World J 2014:902748","journal-title":"Sci World J"},{"key":"9868_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.abb.2015.02.025","volume":"576","author":"GM Cunningham","year":"2015","unstructured":"Cunningham GM, Roman MG, Flores LC et al (2015) The paradoxical role of thioredoxin on oxidative stress and aging. Arch Biochem Biophys 576:32\u201338","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"9868_CR18","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/MCG.0b013e31824e901b","volume":"47","author":"C Tabata","year":"2013","unstructured":"Tabata C, Terada T, Tabata R et al (2013) Serum thioredoxin-1 as a diagnostic marker for malignant peritoneal mesothelioma. J Clin Gastroenterol 47(1):e7\u2013e11","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"9868_CR19","first-page":"2958","volume":"7","author":"F Ciardiello","year":"2001","unstructured":"Ciardiello F, Tortora G (2001) A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7(10):2958\u20132970","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9868_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1742-4658.2009.07448.x","volume":"277","author":"T Mitsudomi","year":"2010","unstructured":"Mitsudomi T, Yatabe Y (2010) Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J 277(2):301\u2013308","journal-title":"FEBS J"},{"issue":"4","key":"9868_CR21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/modpathol.3800067","volume":"17","author":"JK Trupiano","year":"2004","unstructured":"Trupiano JK, Geisinger KR, Willingham MC et al (2004) Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers. Mod Pathol 17(4):476\u2013481","journal-title":"Mod Pathol"},{"issue":"3","key":"9868_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1515\/raon-2015-0019","volume":"49","author":"V Kovac","year":"2015","unstructured":"Kovac V, Dodic-Fikfak M, Arneric N, Dolzan V, Franko A (2015) Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma. Radiol Oncol 49(3):279\u2013285","journal-title":"Radiol Oncol"},{"issue":"4","key":"9868_CR23","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.7314\/APJCP.2015.16.4.1403","volume":"16","author":"H Kaya","year":"2015","unstructured":"Kaya H, Demir M, Taylan M et al (2015) Fibulin-3 as a diagnostic biomarker in patients with malignant mesothelioma. Asian Pac J Cancer Prev 16(4):1403\u20131407","journal-title":"Asian Pac J Cancer Prev"},{"issue":"15","key":"9868_CR24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","volume":"367","author":"HI Pass","year":"2012","unstructured":"Pass HI, Levin SM, Harbut MR et al (2012) Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med 367(15):1417\u20131427","journal-title":"N Engl J Med"},{"issue":"4","key":"9868_CR25","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1083\/jcb.108.4.1547","volume":"108","author":"S Saunders","year":"1989","unstructured":"Saunders S, Jalkanen M, O\u2019Farrell S, Bernfield M (1989) Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol 108(4):1547\u20131556","journal-title":"J Cell Biol"},{"issue":"1","key":"9868_CR26","first-page":"733","volume":"21","author":"Z Orosz","year":"2001","unstructured":"Orosz Z, Kopper L (2001) Syndecan-1 expression in different soft tissue tumours. Anticancer Res 21(1):733\u2013737","journal-title":"Anticancer Res"},{"issue":"3","key":"9868_CR27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q","volume":"186","author":"S Kumar-Singh","year":"1998","unstructured":"Kumar-Singh S, Jacobs W, Dhaene K et al (1998) Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. J Pathol 186(3):300\u2013305","journal-title":"J Pathol"},{"key":"9868_CR28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fonc.2013.00310","volume":"3","author":"T Szatmari","year":"2013","unstructured":"Szatmari T, Dobra K (2013) The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors. Front Oncol 3:310","journal-title":"Front Oncol"},{"issue":"1","key":"9868_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1440-1843.2007.01187.x","volume":"13","author":"M Metintas","year":"2008","unstructured":"Metintas M, Metintas S, Ak G et al (2008) Epidemiology of pleural mesothelioma in a population with non-occupational asbestos\u00a0exposure. Respirology 13(1):117\u2013121","journal-title":"Respirology"},{"issue":"2","key":"9868_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/01913120252959227","volume":"26","author":"VL Roggli","year":"2002","unstructured":"Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT (2002) Malignant mesothelioma and occupational exposure to asbestos: a\u00a0clinicopathological correlation\u00a0of 1445 cases. Ultrastruct Pathol 26(2):55\u201365","journal-title":"Ultrastruct Pathol"},{"issue":"3 Pt 1","key":"9868_CR31","first-page":"L471","volume":"268","author":"DW Kamp","year":"1995","unstructured":"Kamp DW, Israbian VA, Preusen SE, Zhang CX, Weitzman SA (1995) Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: role of iron-catalyzed free radicals. Am J Physiol 268(3 Pt 1):L471\u2013L480","journal-title":"Am J Physiol"},{"issue":"6","key":"9868_CR32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000196364","volume":"61","author":"M Metintas","year":"1994","unstructured":"Metintas M, Ozdemir N, Solak M et al (1994) Chromosome analysis in pleural effusions. Efficiency of this method in the differential diagnosis of pleural effusions. Respiration 61(6):330\u2013335","journal-title":"Respiration"},{"issue":"5","key":"9868_CR33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/mutage\/ger020","volume":"26","author":"M Tomasetti","year":"2011","unstructured":"Tomasetti M, Amati M, Nocchi L et al (2011) Asbestos exposure affects poly (ADP-ribose) polymerase-1 activity: role in asbestos-induced carcinogenesis. Mutagenesis 26(5):585\u2013591","journal-title":"Mutagenesis"},{"issue":"5","key":"9868_CR34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2486\/indhealth.46.484","volume":"46","author":"D Pelclova","year":"2008","unstructured":"Pelclova D, Fenclova Z, Kacer P, Kuzma M, Navratil T, Lebedova J (2008) Increased 8-isoprostane, a marker of oxidative stress in exhaled breath condensate in subjects with asbestos exposure. Ind Health 46(5):484\u2013489","journal-title":"Ind Health"},{"key":"9868_CR35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.biophys.30.1.421","volume":"30","author":"G Powis","year":"2001","unstructured":"Powis G, Montfort WR (2001) Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct 30:421\u2013455","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"9868_CR36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1743-8977-11-24","volume":"11","author":"JK Thompson","year":"2014","unstructured":"Thompson JK, Westbom CM, MacPherson MB et al (2014) Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation. Part Fibre Toxicol 11:24","journal-title":"Part Fibre Toxicol"},{"issue":"6","key":"9868_CR37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1515\/CCLM.2010.165","volume":"48","author":"EK Park","year":"2010","unstructured":"Park EK, Thomas PS, Creaney J, Johnson AR, Robinson BW, Yates DH (2010) Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population. Clin Chem Lab Med 48(6):869\u2013874","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"9868_CR38","doi-asserted-by":"crossref","first-page":"e004145","DOI":"10.1136\/bmjopen-2013-004145","volume":"4","author":"A Cui","year":"2014","unstructured":"Cui A, Jin XG, Zhai K, Tong ZH, Shi HZ (2014) Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis. BMJ Open 4(2):e004145","journal-title":"BMJ Open"},{"issue":"13","key":"9868_CR39","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","volume":"30","author":"K Hollevoet","year":"2012","unstructured":"Hollevoet K, Reitsma JB, Creaney J et al (2012) Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol 30(13):1541\u20131549","journal-title":"J Clin Oncol"},{"issue":"10","key":"9868_CR40","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1164\/rccm.200511-1789OC","volume":"173","author":"A Scherpereel","year":"2006","unstructured":"Scherpereel A, Grigoriu B, Conti M et al (2006) Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med 173(10):1155\u20131160","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"9868_CR41","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3892\/mco.2013.175","volume":"1","author":"K Fukuoka","year":"2013","unstructured":"Fukuoka K, Kuribayashi K, Yamada S, Tamura K, Tabata C, Nakano T (2013) Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma. Mol Clin Oncol 1(6):942\u2013948","journal-title":"Mol Clin Oncol"},{"issue":"9","key":"9868_CR42","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","volume":"6","author":"A Cristaudo","year":"2011","unstructured":"Cristaudo A, Bonotti A, Simonini S et al (2011) Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. J Thorac Oncol 6(9):1587\u20131593","journal-title":"J Thorac Oncol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-016-9868-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-016-9868-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-016-9868-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:04:44Z","timestamp":1692273884000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-016-9868-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["9868"],"URL":"https:\/\/doi.org\/10.1007\/s00408-016-9868-1","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}